Chondroitinase ABC promotes functional recovery after spinal cord injury
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon growth in vitro, and regenerating axons stop at CSPG-rich regions in vivo. Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity. To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Degradation of PNNs has been shown to reactivate early life-like plasticity also in the spinal cord and fear circuitry189,190.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“In rats, iPlasticity induced either by ChABC or fluoxetine improves recovery from spinal cord lesion189,201.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“As chABC removes GAG side chains from CSPGs (Bradbury et al., 2002), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“but also contributed to expanded receptive fields of uninjured primary afferents (Bradbury et al., 2002; Massey et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 1×
“At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)”
BackgroundSelf-citationMcKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“, and regenerating axons stop at CSPG-rich regions in vivo”
BackgroundMoon, L. D. F., Asher, R. A., Rhodes, K. E., & Fawcett, J. W. (2001) · Nature Neuroscience · doi:10.1038/87415 · Cited by 562
Self-citationFunctional regeneration of sensory axons into the adult spinal cord
Ramer, M. S., Priestley, J. V., & McMahon, S. B. (2000) · Nature · doi:10.1038/35002084 · Cited by 517
Self-citationMckeon, R. J., Höke, A., & Silver, J. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1081 · Cited by 486
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury
Levine, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04716.1994 · Cited by 393
Cited by
Items 801–900 of 1,014
Oren‐Suissa, M., Gattegno, T., Kravtsov, V., & Podbilewicz, B. (2017) · Genetics · doi:10.1534/genetics.116.196386 · Cited by 67
“…regeneration in C. elegans mechanosensory neurons The regenerative ability of axons following injury has been previously described in vertebrates and invertebrates (Cajal 1899; Hoy et al. 1967; Devor 1976; Bradbury et al. 2002; Fernandez-Gonzalez et al. 2002; Giordano-Santini et al. 2016).”
BackgroundCS lyases: structure, activity, and applications in analysis and the treatment of diseases.
Linhardt, R., Avci, F., Toida, T., Kim, Y., & Cygler, M. (2006) · Advances in Pharmacology · doi:10.1016/s1054-3589(05)53009-6 · Cited by 62
“In a recent in vivo study in an adult rat spinal cord injury model, the delivery of chondroitinase ABC directly to the injury site promoted functional recovery (Bradbury et al., 2002).”
BackgroundAggrecan is expressed by embryonic brain glia and regulates astrocyte development
Domowicz, M. S., Sanders, T. A., Ragsdale, C. W., & Schwartz, N. B. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2007.12.014 · Cited by 63
Regeneration and Plasticity in the Brain and Spinal Cord
Johansson, B. B. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600486 · Cited by 66
“Chondroitinase ABC promotes functional recovery after spinal cord injury (Bradbury et al, 2002), including bladder function (Caggiano et al, 2005).”
BackgroundNeurogenesis and Apoptotic Cell Death
Moskowitz, M. A., & Lo, E. H. (2003) · Stroke · doi:10.1161/01.str.0000054047.14853.ad · Cited by 62
Lesnikova, A., Casarotto, P. C., Fred, S. M., Voipio, M., Winkel, F., Steinzeig, A., Antila, H., Umemori, J., Biojone, C., & Castrén, E. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.2228-20.2020 · Cited by 56
“Local injections of chondroitinase ABC promote axonal regeneration and functional recovery after spinal cord injury (Bradbury et al., 2002), restore ocular dominance plasticity in the visual cortex (Pizzorusso et al., 2002), and promote extinction of fear memories in rodents (Gogolla et al., 2009).”
BackgroundInfluentialReceptor protein tyrosine phosphatase sigma regulates synapse structure, function and plasticity
Horn, K. E., Xu, B., Gobert, D., Hamam, B. N., Thompson, K. M., Wu, C., Bouchard, J., Uetani, N., Racine, R. J., Tremblay, M. L., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07762.x · Cited by 60
A reassessment of whether cortical motor neurons die following spinal cord injury
Nielson, J. L., Strong, M. K., & Steward, O. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.22661 · Cited by 56
“When used for immunocytochemistry, the antibody stains CST axons in the dorsal column (Akinori, 1998; Mori et al., 1990), and has been used in previous studies for assessment of spared CST fibers following SCI (Bradbury et al., 2002; Starkey et al., 2005).”
MethodChen, M., Geoffroy, C. G., Meves, J. M., Narang, A., Li, Y., Nguyen, M. T., Khai, V. S., Kong, X., Steinke, C. L., Carolino, K. I., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.102 · Cited by 53
“It is generally thought that the glial scar presents a physical barrier and produces chondroitin sulfate proteoglycans (CSPGs) that inhibit axon growth and regeneration (Bradbury et al., 2002; Silver and Miller, 2004).”
Role of immune responses for extracellular matrix remodeling in the ischemic brain
Dzyubenko, E., Manrique‐Castano, D., Kleinschnitz, C., Faissner, A., & Hermann, D. M. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418818092 · Cited by 59
Buckenmeyer, M. J., Meder, T. J., Prest, T. A., & Brown, B. N. (2019) · Methods · doi:10.1016/j.ymeth.2019.07.023 · Cited by 57
Hettiaratchi, M. H., O’Meara, M. J., O’Meara, T. R., Pickering, A. J., Letko-Khait, N., & Shoichet, M. S. (2020) · Science Advances · doi:10.1126/sciadv.abc6378 · Cited by 60
The Biosynthesis and Catabolism of Galactosaminoglycans
Prabhakar, V., & Sasisekharan, R. (2006) · Advances in pharmacology · doi:10.1016/s1054-3589(05)53005-9 · Cited by 64
Myelin—Associated Inhibitory Signaling and Strategies to Overcome Inhibition
Chaudhry, N., & Filbin, M. T. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600407 · Cited by 63
“Altering CSPG levels using enzymes such as chondroitinase ABC, which hydrolyzes the glycosaminoglycan chains of proteoglycan (Bradbury et al, 2002) or DNA enzyme that interfere with glycosaminoglycan synthesis (Grimpe and Silver, 2004), improves regeneration and functional recovery.”
BackgroundFan, Y., Wu, X., Han, S., Zhang, Q., Sun, Z., Chen, B., Xue, X., Zhang, H., Chen, Z., Yin, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40513-5 · Cited by 64
Harlow, D. E., Saul, K. E., Komuro, H., & Macklin, W. B. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5151-14.2015 · Cited by 55
“Statistical significance was defined at p 0.05. creasedbindingtofibronectin,andincreasedOPCmigration(Bradbury et al., 2002; Gudz et al., 2006; Karimi-Abdolrezaee et al., 2012; Starkey et al.,2012).”
BackgroundInfluentialBrain Keratan Sulfate and Glial Scar Formation
ZHANG, H., UCHIMURA, K., & KADOMATSU, K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1377.014 · Cited by 54
Carter, L. M., McMahon, S. B., & Bradbury, E. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.023 · Cited by 55
Self-citationMilbreta, U., Nguyen, L. H., Diao, H., Lin, J., Wu, W., Sun, C., Wang, J., & Chew, S. Y. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00248 · Cited by 57
HB-GAM (pleiotrophin) reverses inhibition of neural regeneration by the CNS extracellular matrix
Paveliev, M., Fenrich, K. K., Kislin, M., Kuja-Panula, J., Kulesskiy, E., Varjosalo, M., Kajander, T., Mugantseva, E., Ahonen-Bishopp, A., Khiroug, L., et al. (2016) · Scientific Reports · doi:10.1038/srep33916 · Cited by 55
DePaul, M. A., Lin, C., Silver, J., & Lee, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-09432-6 · Cited by 59
“(a) Locomotor BBB score of rats prior to the repair surgery (Pre (8)) and following the repair surgery (weeks 9–40).”
Irvine, S., & Kwok, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041172 · Cited by 48
“First described by Golgi as reticular structures in the late 1800s [1], PNNs have since been implicated in pathologies of various neurological disorders, including Alzheimer’s disease, epilepsy and schizophrenia [2–5], as well as in traumatic CNS injuries [6], particularly spinal cord injury (SCI) models [7,8].”
BackgroundMethodA Bibliometric Analysis of Publications on Spinal Cord Injury During 1980–2018
Kiraz, M., & Demir, E. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.01.064 · Cited by 62
Brevican isoforms associate with neural membranes
Seidenbecher, C. I., Smalla, K., Fischer, N., Gundelfinger, E. D., & Kreutz, M. R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01183.x · Cited by 55
Guntinas‐Lichius, O., Angelov, D. N., Morellini, F., Lenzen, M., Skouras, E., Schachner, M., & Irintchev, A. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04424.x · Cited by 55
“Improved recovery from spinal cord injury after application of chondroitinase ABC (Bradbury et al., 2002) is possibly also attributable to enzymatic degradation of the perineuronal nets and concomitant removal of TNR.”
BackgroundIaci, J. F., Vecchione, A. M., Zimber, M. P., & Caggiano, A. O. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2007.0366 · Cited by 61
“…treatment has been shown to improve motor, sensory and autonomic function following both hemisection and contusion injury of the spinal cord (Bradbury et al., 2002; Caggiano et al., 2005; Huang et al., 2006) and alter receptive fields following dorsal column transection (Massey et al.,…”
InfluentialHuman genetic disorders and knockout mice deficient in glycosaminoglycan
Mizumoto, S., Yamada, S., & Sugahara, K. (2014) · BioMed Research International · doi:10.1155/2014/495764 · Cited by 54
“CS-PGs are newly synthesized in the central nervous system following injury, and this inhibits axonal regeneration [10, 248].”
BackgroundNakamura, M., Nakano, K., Morita, S., Nakashima, T., Oohira, A., & Miyata, S. (2009) · Brain Research · doi:10.1016/j.brainres.2008.11.022 · Cited by 54
“…recent studies have shown that CSPGs are responsible for structural plasticity in adult brains such as functional recovery after spinal cord injury (Bradbury et al., 2002), axonal sprouting of cerebellar Purkinje neurons (Corvett and Rossi, 2005), and reactivation of ocular dominance plasticity in…”
Mammalian‐produced chondroitinase AC mitigates axon inhibition by chondroitin sulfate proteoglycans
Curinga, G., Snow, D. M., Mashburn, C. B., Köhler, K., Thobaben, R., Caggiano, A. O., & Smith, G. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04530.x · Cited by 55
Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damage
Roll, L., & Faissner, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00219 · Cited by 55
Biologic Scaffold for CNS Repair
Meng, F., Modo, M., & Badylak, S. F. (2014) · Regenerative Medicine · doi:10.2217/rme.14.9 · Cited by 54
Raman spectroscopic investigation of spinal cord injury in a rat model
Saxena, T. K., Deng, B., Hasenwinkel, J. M., Stelzner, D. J., & Chaiken, J. (2011) · Journal of Biomedical Optics · doi:10.1117/1.3549700 · Cited by 54
Proteomics, Glycomics, and Glycoproteomics of Matrisome Molecules
Raghunathan, R., Sethi, M. K., Klein, J., & Zaia, J. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r119.001543 · Cited by 56
“treatment of the injury site with chondroitinase enzymes (55, 56) with the implication that CSPGs maintain the extracellular”
BackgroundWang, X., Zhou, T., Maynard, G. D., Terse, P., Cafferty, W. B. J., Kocsis, J. D., & Strittmatter, S. M. (2020) · Brain · doi:10.1093/brain/awaa116 · Cited by 57
“Reactive astrocytes, as well as neurons, produce chondroitin sulphate proteoglycans (CSPGs), and reactive sprouting is augmented when these molecules are digested with chondroitinase after SCI (Bradbury et al., 2002; Wang et al., 2011a; James et al., 2015; Hu et al., 2018; Warren et al., 2018; Rosenzweig et al., 2019).”
BackgroundDusart, I., Ghoumari, A. M., Wehrlé, R., Morel, M., Bouslama‐Oueghlani, L., Camand, E., & Sotelo, C. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.11.007 · Cited by 57
Kawano, H., Li, H.-P., Sango, K., Kawamura, K., & Raisman, G. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20441 · Cited by 54
“, 2001) and spinal descending (Yick et al., 2000; Bradbury et al., 2002) systems.”
BackgroundEphA4 deficient mice maintain astroglial–fibrotic scar formation after spinal cord injury
Herrmann, J. E., Shah, R. R., Chan, A. F., & Zheng, B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.02.005 · Cited by 54
“SCI (Bradbury et al., 2002).”
Retinal transplantation: progress and problems in clinical application
Lund, R. D., Ono, S. J., Keegan, D., & Lawrence, J. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103041 · Cited by 57
“, spinal cord repair, improved regeneration can be achieved by modulating these barriers [136, 137].”
BackgroundPerisynaptic barrier of proteoglycans in the mature brain and spinal cord
Murakami, T., & Ohtsuka, A. (2003) · Archives of Histology and Cytology · doi:10.1679/aohc.66.195 · Cited by 53
Promotion of axonal regeneration in the injured CNS
Selzer, M. E. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00322-3 · Cited by 62
Li, H.-J., Pan, Y.-B., Sun, Z.-L., Sun, Y.-Y., Yang, X.-T., & Feng, D.-F. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.028 · Cited by 54
“We further examined the changes in CSPGs following treatment of injured optic nerves with miR-21 by immunoblotting and immunohistochemistry at 35 days after ONC.”
Baculovirus Envelope Protein ODV-E66 Is a Novel Chondroitinase with Distinct Substrate Specificity
Sugiura, N., Setoyama, Y., Chiba, M., Kimata, K., & Watanabe, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.251157 · Cited by 55
McKerracher, L. J., & Anderson, K. D. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2013.2909 · Cited by 58
“17,18 Rho is neuroprotective for oligodendrocytes, 8 and inactivation of Rho in oligodendrocytes is reported to enhance the remyelination process.”
Barbour, H. R., Plant, C. D., Harvey, A. R., & Plant, G. W. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-106 · Cited by 55
“Supplementation of glial transplants with neurotrophins may improve cell survivability [13] and in combination with removal of the glial scar by the use of chondroitinase could potentially improve axonal regeneration in this 14 day delayed glial transplant model [102,103].”
BackgroundKarumbaiah, L., Anand, S., Thazhath, R., Zhong, Y., Mckeon, R. J., & Bellamkonda, R. V. (2011) · Glia · doi:10.1002/glia.21170 · Cited by 52
“Further, chondroitinase ABC (chABC) treatment of the glial scar resulted in significant enhancement of neurite outgrowth (Becker and Becker, 2002; Bradbury et al., 2002; Lee et al., 2009; McKeon et al., 1995).”
BackgroundGlycosaminoglycans, Protein Aggregation and Neurodegeneration
Papy-García, D., Christophe, M., Huynh, M. B., Siñeriz, F., Sissoëff, L., Sepulveda-Diaz, J. E., & Raisman‐Vozari, R. (2011) · Current Protein and Peptide Science · doi:10.2174/138920311795860188 · Cited by 58
“For instance, chondroitin 6-sulfate synthesis was clearly upregulated in the CNS after injury and inhibited axon regeneration [27-28].”
BackgroundRole of Glial Cells in Axonal Regeneration
Toy, D., & Namgung, U. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.2.68 · Cited by 60
“with chondroitinase ABC (ChABC) enzymes, which remove GAG chains [64, 65].”
BackgroundGianola, S., & Rossi, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03190.x · Cited by 54
Shichinohe, H., Kuroda, S., Tsuji, S., Yamaguchi, S., Yano, S., Lee, J.-B., Kobayashi, H., Kikuchi, S., Hida, K., & Iwasaki, Y. (2008) · Neurorehabilitation and neural repair · doi:10.1177/1545968308315596 · Cited by 53
Hamilton, L., Franklin, R. J. M., & Jeffery, N. D. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-77 · Cited by 53
“Such extended testing might also be of benefit for screening many poten- Page 1 of 11 (page number not for citation purposes) tial pharmacological interventions such as chondroitinase ABC [19], or combinations of therapies [20,21] prior to application in humans.”
BackgroundMicroscale Surgery on Single Axons
Sretavan, D. W., Chang, W. C. W., Hawkes, E., Keller, C. G., & Kliot, M. (2005) · Neurosurgery · doi:10.1093/neurosurgery/57.4.635 · Cited by 56
“After spinal cord lesions in rodents, the regeneration of several hundred axons has been reported to correlate with some recovery of function (10, 13, 37), and it is generally agreed that the survival of a fraction of axons within a pathway is sufficient to maintain some degree of useful function (4, 33, 43, 46, 59).”
BackgroundExpression pattern of NOGO-A protein in the human nervous system
Buss, A., Sellhaus, B., Wolmsley, A., Noth, J., Schwab, M. E., & Brook, G. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0942-z · Cited by 53
“The latter comprise extracellular matrix proteins such as semaphorin 3A [11], chondroitin sulphate proteoglycans (CSPG) [ 1 ] and myelin-associated proteins such as NOGO-A, myelin associated glycoprotein (MAG) and oligodendrocyte myelin glycoprotein (OMgp) [7, 16, 17, 18].”
BackgroundNeurite elongation on chondroitin sulfate proteoglycans is characterized by axonal fasciculation
Snow, D. M., Smith, J. D., Cunningham, A. T., McFarlin, J. M., & Goshorn, E. C. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00034-7 · Cited by 59
Tran, A. P., Warren, P. M., & Silver, J. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113276 · Cited by 55
Li, H.-P., Komuta, Y., Kimura‐Kuroda, J., Kuppevelt, T. H. V., & Kawano, H. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2513 · Cited by 52
“…only a few studies reported the inhibitory effect of DS. 52 Oversulfated DS binds to various heparin-binding growth factors including pleiotrophin, midkine, and fibroblast growth factor-2, 7, 10, and 18, 53,54 and the neurite outgrowth-promoting activity of DS is dependent on these growth factors.”
Starkey, M. L., Bleul, C., Maier, I. C., & Schwab, M. E. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.006 · Cited by 49
“…of myelin-associated growth inhibitors (Thallmair et al., 1998; Fournier et al., 2001), neurotrophins (Zhou and Shine, 2003), removal of chondroitin sulphate proteoglycans (Bradbury et al., 2002; Barritt et al., 2006) or enhanced activity (Brus-Ramer et al., 2007; Maier et al., 2008; Carmel Fig.”
InfluentialAgudo‐Barriuso, M., Yip, P. K., Davies, M., Bradbury, E. J., Doherty, P., McMahon, S. B., Maden, M., & Corcoran, J. P. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.018 · Cited by 61
“The behavioural tests were carried out as previously described (Bradbury et al., 2002).”
InfluentialSelf-citationLi, Z., Tang, R.-H., Zhang, J., Tang, Z., Qu, W., Zhu, W., Li, J., Xie, M.-J., Tian, D., & Wang, W. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.03.007 · Cited by 53
Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats
Rochkind, S., Shahar, A., Fliss, D. M., El‐Ani, D., Astachov, L., Hayon, T., Alon, M., Zamostiano, R., Ayalon, O. B., Biton, I. E., et al. (2005) · European Spine Journal · doi:10.1007/s00586-005-0981-8 · Cited by 52
“Other promising strategies focus on creating a receptive environment for regeneration by abolishing the myelin-associated inhibitors of axonal growth and the physical and biochemical barrier, the so-called ‘‘glial scar’’ [ 7 , 17, 40, 48, 53].”
Shields, L. B. E., Zhang, Y. P., Burke, D. A., Gray, R., & Shields, C. B. (2008) · Surgical Neurology · doi:10.1016/j.surneu.2008.02.009 · Cited by 58
“Nonetheless, we failed to observe the robust axonal regeneration noted by Bradbury and colleagues [5] exhibited by bundles of axons that grew 2 mm through the lesion and several fibers that extended 4 mm beyond the lesion.”
BackgroundMethodInfluentialExpression of neurocan after transient middle cerebral artery occlusion in adult rat brain
Deguchi, K., Takaishi, M., Hayashi, T., Oohira, A., Nagotani, S., Li, F., Jin, G., Nagano, I., Shoji, M., Miyazaki, M., et al. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.016 · Cited by 52
Opioid administration following spinal cord injury: Implications for pain and locomotor recovery
Woller, S. A., & Hook, M. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.008 · Cited by 61
“of injury, astrocytes play a crucial role in restricting inflammation and protecting neurons (Bradbury et al., 2002; Hu et al., 2010).”
InfluentialRewiring of regenerated axons by combining treadmill training with semaphorin3A inhibition
Zhang, L., Kaneko, S., Kikuchi, K. M., Sano, A., Maeda, M., Kishino, A., Shibata, S., Mukaino, M., Toyama, Y., Liu, M., et al. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-14 · Cited by 53
“Neutralizing one (or several) of these molecules enhances axonal regeneration and results in some degree of functional recovery [10,16,17].”
BackgroundInhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses
Nagai, J., Owada, K., Kitamura, Y., Goshima, Y., & Ohshima, T. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.01.015 · Cited by 55
Dhillon, R., Parker, J., Syed, Y. A., Edgley, S. A., Young, A. M. H., Fawcett, J. W., Jeffery, N. D., Franklin, R. J. M., & Kotter, M. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0359-7 · Cited by 55
“The notion that the observed increase of serotonergic fibres is a result of axonal regeneration is supported by the concomitant presence of Gap43, a protein that is expressed during high-growth states of axons [5, 7], and which was detected above, below, and at the site of previous compression.”
Self-citationMukherjee, N., Adak, A., & Ghosh, S. (2020) · Soft Matter · doi:10.1039/d0sm00885k · Cited by 55
Moreno-Flores, M. T., Bradbury, E. J., Martín‐Bermejo, M. J., Agudo‐Barriuso, M., Lim, F., Pastrana, É., Ávila, J., Díaz‐Nido, J., McMahon, S. B., & Wandosell, F. G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.014 · Cited by 52
Self-citationMyelin inhibitors: does NO mean GO?
Raisman, G. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1328 · Cited by 52
“However, it seems increasingly likely that this prevention of growth is associated not with oligodendrocytes and central myelin, but with reactive astrocyte”
BackgroundEffects of Digesting Chondroitin Sulfate Proteoglycans on Plasticity in Cat Primary Visual Cortex
Vorobyov, V., Kwok, J. C. F., Fawcett, J. W., & Sengpiel, F. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2283-12.2013 · Cited by 50
“Indeed, degradation of CSPGs by the bacterial enzyme chondroitinase ABC (ChABC), which cleaves the GAG chains, promotes functional recovery after spinal cord injury (Bradbury et al., 2002).”
Self-citationFloriddia, E. M., Rathore, K. I., Tedeschi, A., Quadrato, G., Wuttke, A., Lueckmann, J.-M., Kigerl, K. A., Popovich, P. G., & Giovanni, S. D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1925-12.2012 · Cited by 53
“…injury (Savio and Schwab, 1990; Schnell and Schwab, 1990; McKerracher et al., 1994; Bregman et al., 1995; Davies et al., 1999; Chen et al., 2000; Bradbury et al., 2002; GrandPré et al., 2002; Kottis et al., 2002; Sroga et al., 2003; Silver and Miller, 2004; Yiu and He, 2006; Hellal et al.,…”
BackgroundEndogenous Proliferation after Spinal Cord Injury in Animal Models
McDonough, A., & Martínez‐Cerdeño, V. (2012) · Stem Cells International · doi:10.1155/2012/387513 · Cited by 64
“Researchers have followed different experimental strategies to modulate proliferation and cell differentiation in the spinal cord, including the manipulation of the levels of growth factors [11–18], proteins in the glial scar [19, 20], inflammation [21– 23], and factors known to impair regeneration [24, 25].”
BackgroundKakabadze, Z., Kipshidze, N., Mardaleishvili, K., Chutkerashvili, G., Chelishvili, I., HARDERS, A. G., Loladze, G., Shatirishvili, G., Kipshidze, N., Chakhunashvili, D., et al. (2016) · Stem Cells International · doi:10.1155/2016/6768274 · Cited by 51
“…axons using neurotrophins, which can help with the establishment of appropriate connections between regenerating axons and target neurons and, thus, provide functional recovery [26], by neutralizing inhibitory molecules associated with the failure of axonal regeneration [27] and many others.”
Adult rat myelin enhances axonal outgrowth from neural stem cells
Poplawski, G. H. D., Lie, R., Hunt, M., Kumamaru, H., Kawaguchi, R., Lu, P., Schäfer, M. K. E., Woodruff, G., Robinson, J., Canete, P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2563 · Cited by 50
Kim, Y., Kang, H., Powathil, G., Kim, H., Trucu, D., Lee, W., Lawler, S. E., & Chaplain, M. A. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204865 · Cited by 58
Lee, J., Shin, J. E., Lee, B., Kim, H., Jeon, Y., Ahn, S. H., Chi, S. W., & Cho, Y. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920829117 · Cited by 54
Das, D., & Goyal, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8005-1_15 · Cited by 51
Role and therapeutic implications of protein glycosylation in neuroinflammation
Rebelo, A. L., Chevalier, M. T., Russo, L., & Pandit, A. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.01.004 · Cited by 50
Sun, X., Liu, H., Tan, Z., Hou, Y., Pang, M., Chen, S., Xiao, L., Yuan, Q., Liu, B., Rong, L., et al. (2022) · Small · doi:10.1002/smll.202205012 · Cited by 58
Saraswathy, V. M., Zhou, L., & Mokalled, M. H. (2024) · Nature Communications · doi:10.1038/s41467-024-50628-y · Cited by 57
Bretzner, F., Plemel, J. R., Liu, J., Richter, M. W., Roskams, A. J., & Tetzlaff, W. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22440 · Cited by 54
“…(Aguayo et al., 1981; Richardson et al., 1984; Li et al., 1997; Rapalino et al., 1998; Liu et al., 1999; Raineteau et al., 2001; Qiu et al., 2002; Bradbury et al., 2002; Dergham et al., 2002; Fournier et al., 2003; Rossignol et al., 2007), including the transplantation of olfactory ensheathing…”
BackgroundAnti‐inflammatory effects of ADAMTS‐4 in a mouse model of ischemic stroke
Lemarchant, S., Dhungana, H., Pomeshchik, Y., Leinonen, H., Kołosowska, N., Korhonen, P., Kanninen, K. M., García‐Berrocoso, T., Montaner, J., Malm, T., et al. (2016) · Glia · doi:10.1002/glia.23017 · Cited by 50
Wilems, T. S., Vardhan, S., Wu, S., & Sakiyama‐Elbert, S. E. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.03.004 · Cited by 53
“Cleavage of the GAG side chains from the core protein of CSPGs via enzymatic treatment with chondroitinase ABC (chABC) improves axonal extension and cell migration into and through the injured area, with some studies showing improvements in functional outcomes (Hu et al. 2018; Bradbury et al. 2002; Bartus et al. 2014).”
BackgroundAdvances in glycosaminoglycan detection
Khan, S. A., Mason, R. W., Kobayashi, H., Yamaguchi, S., & Tomatsu, S. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.03.004 · Cited by 51
Sato, Y., Nakanishi, K., Hayakawa, M., Kakizawa, H., Saito, A. M., Kuroda, Y., Ida‐Eto, M., Tokita, Y., Aono, S., Matsui, F., et al. (2008) · Reproductive Sciences · doi:10.1177/1933719108317299 · Cited by 52
Kurihara, D., & Yamashita, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.314070 · Cited by 46
“Digestion of CSPGs by chondroitinase ABC treatment enhances functional recovery after spinal cord injury in rats (2).”
BackgroundHossain-Ibrahim, M. K., Rezajooi, K., Stallcup, W. B., Lieberman, A. R., & Anderson, P. N. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-80 · Cited by 50
“NG2 is the most strongly upregulated CSPG at CNS injury sites, with a time course very closely matched to the arrested growth of axonal sprouts [13,27], and enzymatic degradation of CSPGs (in particular, removal of chondroitin sulphate glycosaminoglycans by chondroitinase ABC) promotes regenerative axonal growth in th…”
BackgroundNogo and Nogo‐66 receptor in human and chick: Implications for development and regeneration
O'Neill, P., Whalley, K., & Ferretti, P. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20116 · Cited by 50
“These factors include chondroitin sulphate proteoglycans (Zuo et al., 1998; Bradbury et al., 2002), myelin-associated glycoprotein (McKerracher et al., 1994; Mukhopadhyay et al., 1994), and Nogo (Varga et al., 1995).”
BackgroundProteoglycans: Road Signs for Neurite Outgrowth
Snow, D., & Beller, J. A. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.128235 · Cited by 54
“…ABC (cABC), which removes the chondroitin sulfate chains of CSPGs, can improve neuronal growth across the glial scar and improve functional outcome (Bradbury and Carter, 2011; Bradbury et al., 2002; Garcia-Alias et al., 2009; Huang et al., 2006; Massey et al., 2006; Tom et al., 2009).”
Bao, X., Pavão, M. S. G., dos Santos, J. C., & Sugahara, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503036200 · Cited by 50
Webber, D. J., Bradbury, E. J., McMahon, S. B., & Minger, S. L. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.6.929 · Cited by 50
“To ensure that a complete lesion of the dorsal columns at C4 had been achieved, lumbar tissue embedded in gelatin was cut transversely and processed for PKCγ immunocytochemistry [54].”
MethodSelf-citationInduced expression of polysialic acid in the spinal cord promotes regeneration of sensory axons
Zhang, Y., Ghadiri-Sani, M., Zhang, X., Richardson, P. M., Yeh, J., & Bo, X. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.02.011 · Cited by 49
Tang, H., Gu, Y., Jiang, L., Zheng, G., Pan, Z., & Jiang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1070540 · Cited by 57
“2 Pivotal immune chemicals released by astrocytes Following SCI, reactive astrocytes in the glial scar produce high levels of CSPGs (44), which were initially known to inhibit axonal growth and regeneration (45), but were later found to be beneficial in spinal cord recovery (46).”
BackgroundMethodClinical Trials Targeting Secondary Damage after Traumatic Spinal Cord Injury
Khaing, Z. Z., Chen, J. Y., Safarians, G., Ezubeik, S., Pedroncelli, N., Duquette, R. D., Prasse, T., & Seidlits, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043824 · Cited by 49
Delayed Applications of L1 and Chondroitinase ABC Promote Recovery after Spinal Cord Injury
Lee, H. J., Bian, S., Jakovčevski, I., Wu, B., Irintchev, A., & Schachner, M. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2290 · Cited by 50
“…since these terminals are embedded in the perineuronal nets of moto-neurons, which are extracellular matrix formations thought to restrict plasticity in adult mammals, and believed to be the main target of Chase (Bradbury et al., 2002; Carulli et al., 2010; Fawcett, 2009; Massey et al., 2006).”
InfluentialYoshioka, N., Hisanaga, S., & Kawano, H. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22431 · Cited by 52
Yoon, C., Van Niekerk, E. A., Henry, K., Ishikawa, T., Orita, S., Tuszynski, M. H., & Campana, W. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478552 · Cited by 46
“Rather, we used this model because it is of established value in determining whether candidate therapies enhance the plasticity and regeneration of CNS axons that otherwise fail to grow after spinal cord injury (34,36,41-43) Indeed, our findings reveal significant effects of LRP1 agonists on axonal growth after injury…”
BackgroundMethodMingorance, A., Solé, M., Muñetón‐Gómez, V. C., Martínez, A., Nieto‐Sampedro, M., Soriano, E., & del Río, J. A. (2006) · The FASEB Journal · doi:10.1096/fj.05-5121fje · Cited by 52
“Among others, current strategies to block myelinand CSPG-induced inhibition include extrinsic approaches, such as treatment with anti-Nogo-A or NgR receptor antibodies, NgR antagonist peptide (NEP1-40), NgR-receptor extracellular fragments (16–18), and enzymatic proteoglycan hydrolysis with chondroitinase ABC (ChABC)…”
BackgroundUeno, H., Suemitsu, S., Okamoto, M., Matsumoto, Y., & Ishihara, T. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.041 · Cited by 55
“In the spinal cord, chondroitinase ABC treatment promoted functional collateral sprouting (Bradbury et al., 2002; Guillermo et al., 2009).”
BackgroundSato, Y., Nakanishi, K., Tokita, Y., Kakizawa, H., Ida, M., Maeda, H., Matsui, F., Aono, S., Saito, A., Kuroda, Y., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05107.x · Cited by 46
Nogo-C is sufficient to delay nerve regeneration
Kim, J., Bonilla, I. E., Qiu, D., & Strittmatter, S. M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00076-9 · Cited by 49
“, 2002) and to axon growth inhibitors in the CNS environment (David and Aguayo, 1981; Benfey and Aguayo, 1982; Bandtlow et al., 1990; Bregman et al., 1995; Fournier and Strittmatter, 2001; Bradbury et al., 2002).”
Influential
Metadata
- Authors
- Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B.
- Affiliations
- King's College London (GB)
- University of Cambridge (GB)
- University of London (GB)
- Corresponding author
- Bradbury, Elizabeth J.
- ORCID
- Venue
- Nature
- Published
- 2002-04
- Volume
- 416
- Issue
- 6881
- Pages
- 636-640
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012928251
- Cited by
- 2,357
- References
- 31
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 54 · 2023: 73 · 2022: 98 · 2021: 95 · 2020: 116 · 2019: 91 · 2018: 109 · 2017: 96 · 2016: 104 · 2015: 111 · 2014: 131 · 2013: 108 · 2012: 137
- FWCI
- 63.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondroitinase ABC, spinal cord injury, chondroitin sulfate proteoglycans, glycosaminoglycan degradation, axon regeneration, glial scar, corticospinal tract, sensory axon regeneration, locomotor recovery, proprioception, central nervous system injury
- MeSH terms
- Animals, Axons, Electrophysiology, Ganglia, Spinal, Humans, Isoenzymes, Male, Motor Activity, Nerve Crush, Nerve Regeneration, Neurons, Protein Kinase C, Psychomotor Performance, Spinal Cord Injuries, Up-Regulation, Rats, Wistar, Chondroitin ABC Lyase, GAP-43 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.